Status:
TERMINATED
Diagnosis and Treatment of Patients With Cystic Fibrosis
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Cystic Fibrosis
Liver Disease or Abnormalities
Eligibility:
All Genders
4-120 years
Brief Summary
This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of the study is to obtain samples and data collected during standard clinical care for future research to expan...
Detailed Description
This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of the study is to obtain samples and data collected during standard clinical care for future research to expan...
Eligibility Criteria
- INCLUSION CRITERIA
- Patients with known or suspected CF and family members of patients with CF.
- >=4 years of age
EXCLUSION CRITERIA
-Concomitant medical, psychiatric or other problems which might complicate interpretation of studies of CF, or for which we are unable to provide adequate care.
Key Trial Info
Start Date :
January 1 1988
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 30 2026
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT00001223
Start Date
January 1 1988
End Date
January 30 2026
Last Update
February 4 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892